Faes Farma revenue and financials

FAE · BME · EUR

€4.74Change from previous close: −0.21%Absolute change: −€0.01

Close · October 7, 2026

In the fiscal year ended December 2025, Faes Farma reported revenue of €610.46M (+23.66% year over year). Net income was €79.63M, a net margin of 13.0%.

Annual revenue · 2025: €610.46M
  1. €438.75M2022
  2. €451.17M2023
  3. €493.65M2024
  4. €610.46M2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+23.66%
2025 vs 2024
Net income growth
−28.49%
2025 vs 2024
Net margin
13.0%
2024: 22.6%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Cash flow · Annual
Item20252024202320222021
Operating cash flow78.5115101107—
Depreciation and amortization29.020.319.419.3—
Capital expenditure-23.6-39.6-102-80.9—
Investing cash flow-299-34.2-97.4-92.4—
Financing cash flow274-51.7-35.4-18.5—
Dividends paid-55.7-48.2-14.6-18.1—
Share repurchases—0.0-17.70.00.0
Debt issued3750.00.32.3—
Debt repaid-46.9-3.5-3.3-2.6—
Net change in cash53.129.6-31.8-3.8—
Free cash flow54.875.9-1.226.1—